What is acute cholecystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Acute Cholecystitis?

Acute cholecystitis is an acute inflammatory condition of the gallbladder, most commonly (90-95% of cases) caused by gallstone obstruction of the cystic duct, presenting with right upper quadrant pain, fever, and leukocytosis. 1, 2

Epidemiology and Pathophysiology

  • Acute cholecystitis develops in 1-3% of patients with symptomatic gallstones 1
  • Approximately 200,000 cases are diagnosed annually in the United States 2
  • Calculous cholecystitis (with gallstones) accounts for 90-95% of cases, while acalculous cholecystitis (without gallstones) represents 5-10% and typically occurs in critically ill patients 2, 3
  • The mortality rate is approximately 3% overall but increases significantly with age and comorbidities 4

Clinical Presentation

The classic triad consists of: 1

  • Right upper quadrant pain (often postprandial)
  • Fever
  • Leukocytosis

Physical examination typically reveals right upper quadrant tenderness with a positive Murphy's sign 1

Diagnostic Approach

Ultrasound is the first-line imaging modality of choice with sensitivity of approximately 81% and specificity of 83% 1, 2

Key ultrasound findings include: 1

  • Pericholecystic fluid (fluid around the gallbladder)
  • Distended gallbladder
  • Edematous/thickened gallbladder wall (≥3.5 mm)
  • Gallstones
  • Sonographic Murphy's sign

When ultrasound is non-diagnostic, hepatobiliary scintigraphy (HIDA scan) is the gold standard confirmatory test 2

Treatment Strategy

Standard Management for Surgical Candidates

Early laparoscopic cholecystectomy (ELC) within 7 days of symptom onset—ideally within 72 hours of diagnosis—is the definitive treatment and standard of care 1, 5, 6, 7, 2

Benefits of early surgery include: 1

  • Shorter recovery time and hospitalization
  • Lower hospital costs
  • Fewer work days lost
  • Greater patient satisfaction
  • Reduced risk of recurrent symptoms and complications

Uncomplicated vs Complicated Disease

For uncomplicated acute cholecystitis in Class A or B patients (low-risk surgical candidates): 1

  • Perform urgent cholecystectomy
  • No postoperative antibiotics are necessary if source control is complete 1

For complicated acute cholecystitis (gangrenous, perforated, or with abscess): 1

  • Class A or B patients: urgent cholecystectomy with short-course postoperative antibiotics (1-4 days)
  • Class C patients (high-risk): emergent cholecystectomy with postoperative antibiotic therapy

Special Populations

Elderly patients (>65 years): 1, 2

  • Early laparoscopic cholecystectomy should still be performed when feasible
  • Surgery within 10 days of symptom onset is safe, though earlier is better
  • Laparoscopic cholecystectomy is associated with lower 2-year mortality (15.2%) compared with nonoperative management (29.3%) 2

Pregnant patients: 2

  • Early laparoscopic cholecystectomy is recommended during all trimesters
  • Associated with lower maternal-fetal complications (1.6% for early vs 18.4% for delayed)

Transplanted or immunocompromised patients: 1

  • Laparoscopic cholecystectomy should be performed as soon as possible after diagnosis
  • These patients have higher severity and mortality risk

Alternative Management for High-Risk Patients

Percutaneous cholecystostomy is indicated for: 1

  • Critically ill patients with multiple comorbidities unfit for surgery (ASA III/IV)
  • Patients with septic shock or severe hemodynamic instability
  • Patients who fail to improve after 3-5 days of antibiotic therapy

Important caveats about cholecystostomy: 1, 2

  • Should be considered a bridge to surgery rather than definitive treatment in most cases
  • Associated with higher postprocedural complications (65%) compared to laparoscopic cholecystectomy (12%) 2
  • Clinical resolution typically occurs within 24-48 hours in 92% of patients 1
  • Conservative treatment (antibiotics alone or with drainage) leads to frequent recurrence and should not be considered definitive therapy 8

Gallbladder Perforation

Early diagnosis and immediate surgical intervention are critical as perforation occurs in 2-11% of acute cholecystitis cases with mortality rates of 12-16% 1

Three types of perforation: 1

  • Type I (acute/free): generalized peritonitis requiring emergency surgery
  • Type II (subacute): pericholecystic abscess with localized peritonitis
  • Type III (chronic): cholecystoenteric fistula

Antibiotic Therapy

Empirical broad-spectrum antibiotics should be initiated promptly: 5, 6

  • Non-critical patients: amoxicillin/clavulanate 6
  • Critically ill patients: piperacillin-tazobactam 5, 6
  • Duration depends on disease severity and source control adequacy 1

Common Pitfalls to Avoid

  • Do not delay surgery beyond 7-10 days from symptom onset as inflammation becomes more difficult to manage and conversion rates increase 1, 7
  • Do not routinely use delayed cholecystectomy (6-12 weeks later) as this approach results in higher recurrence rates, longer total hospitalization, and increased complications 1
  • Do not rely solely on conservative management as 76% of patients eventually require cholecystectomy, with 36% experiencing readmission 8
  • Do not overlook acalculous cholecystitis in critically ill patients as it carries high mortality if diagnosis is delayed 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute acalculous cholecystitis.

Current gastroenterology reports, 2003

Research

[Management of Acute Cholecystitis].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2018

Guideline

Emphysematous Cholecystitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Colecistitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.